Qube Research & Technologies (QRT)’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-56
Closed -$168 3449
2024
Q2
$168 Sell
56
-72,923
-100% -$219K ﹤0.01% 3013
2024
Q1
$339K Buy
72,979
+68,005
+1,367% +$316K ﹤0.01% 2337
2023
Q4
$20.6K Buy
4,974
+1,136
+30% +$4.7K ﹤0.01% 3055
2023
Q3
$11.5K Sell
3,838
-41,691
-92% -$125K ﹤0.01% 2856
2023
Q2
$112K Buy
+45,529
New +$112K ﹤0.01% 1853